Written Question·Department of Health and Social Care·UIN 20468

Medicines and Healthcare products Regulatory Agency: Finance

Tabled: 16 December 2024

Answered: 31 December 2024

Question

Rupert Lowe

To ask the Secretary of State for Health and Social Care, if will make an assessment of the potential merits of conducting a review into the funding of the Medicines and Healthcare products Regulatory Agency.

Answer

Karin Smyth

There is currently no planned review of the funding of the Medicines and Healthcare products Regulatory Agency (MHRA).The MHRA is funded predominately by charging fees to industry, for the services it delivers, with additional funding being provided by th...

ⓘ

This is an extract from the Parliament API. Search the full answer on Parliament.uk (UIN 20468) →